Similar articles

• Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.

  Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H. Amling CL, et al. J Urol. 2000 Jul;164(1):101-5. J Urol. 2000. PMID: 10840432
• Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.

  Valotto C, Falconieri G, Pizzolitto S, Cerruto MA, Brondani G, De Gobbi A, Zattoni F. Valotto C, et al. Arch Ital Urol Androl. 2011 Jun;83(2):78-82. Arch Ital Urol Androl. 2011. PMID: 21826879
• Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.

  Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Ramos CG, et al. J Urol. 2004 Jul;172(1):137-40. doi: 10.1097/01.ju.0000132139.40964.75. J Urol. 2004. PMID: 15201754
• Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease.

  Ward JF, Nowacki M, Sands JP, Conner RJ, Huisman TK. Ward JF, et al. J Urol. 1996 Oct;156(4):1381-4; discussion 1384-5. doi: 10.1016/s0022-5347(01)65591-5. J Urol. 1996. PMID: 8808876
• Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy.

  van den Ouden D, Hop WC, Schröder FH. van den Ouden D, et al. J Urol. 1998 Oct;160(4):1392-7. doi: 10.1097/00005392-199810000-00048. J Urol. 1998. PMID: 9751362 Review.